Related Experiment Video
Updated: Feb 4, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase
Laurie G Hudson1,2, Jennifer M Gillette3,4, Huining Kang5,6
1Department of Pharmaceutical Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA. lhudson@salud.unm.edu.
Abstract:
The tumor microenvironment for epithelial ovarian cancer is complex and rich in bioactive molecules that modulate cell-cell interactions and stimulate numerous signal transduction cascades. These signals ultimately modulate all aspects of tumor behavior including progression, metastasis and therapeutic response. Many of the signaling pathways converge on the small GTPase Ras-related C3 botulinum toxin substrate (Rac)1. In addition to regulating actin cytoskeleton remodeling necessary for tumor cell adhesion, migration and invasion, Rac1 through its downstream effectors, regulates cancer cell survival, tumor angiogenesis, phenotypic plasticity, quiescence, and resistance to therapeutics. In this review we discuss evidence for Rac1 activation within the ovarian tumor microenvironment, mechanisms of Rac1 dysregulation as they apply to ovarian cancer, and the potential benefits of targeting aberrant Rac1 activity in this disease. The potential for Rac1 contribution to extraperitoneal dissemination of ovarian cancer is addressed.
Insights
The small GTPase Ras-related C3 botulinum toxin substrate (Rac)1 plays a key role in ovarian cancer progression and metastasis. Targeting Rac1 may offer new therapeutic strategies for epithelial ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The tumor microenvironment (TME) in epithelial ovarian cancer (EOC) is complex, featuring bioactive molecules that influence cell interactions and signaling pathways.
- These signals impact tumor progression, metastasis, and response to therapy.
- Many signaling pathways converge on the small GTPase Ras-related C3 botulinum toxin substrate (Rac)1.
Purpose of the Study:
- To review evidence of Rac1 activation in the ovarian TME.
- To discuss mechanisms of Rac1 dysregulation in ovarian cancer.
- To explore the potential benefits of targeting Rac1 in this disease.
Main Methods:
- Literature review of studies on Rac1 in ovarian cancer.
- Analysis of Rac1's role in TME signaling.
- Examination of Rac1's downstream effectors and their impact on tumor behavior.
Main Results:
- Rac1 regulates actin cytoskeleton remodeling, crucial for tumor cell adhesion, migration, and invasion.
- Rac1 influences cancer cell survival, tumor angiogenesis, phenotypic plasticity, quiescence, and therapeutic resistance.
- Evidence suggests Rac1 activation and dysregulation within the ovarian TME.
Conclusions:
- Rac1 is a critical regulator of multiple processes in ovarian cancer.
- Targeting aberrant Rac1 activity presents a potential therapeutic strategy.
- Rac1 may contribute to the extraperitoneal dissemination of ovarian cancer.
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
The Tumor Microenvironment
Convergent Evolution
Region of Convergence
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...

